FCE 23762

Known as: FCE-23762 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-1999
012319921999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
We conducted a clinical evaluation of FCE 23762, a methoxymorpholino analog of doxorubicin, in 48 dogs with metastatic… (More)
Is this relevant?
1999
1999
PNU 145156E (formerly FCE 26644) is a noncytotoxic molecule whose antitumor activity is exerted through the formation of a… (More)
  • figure 2
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
1997
1997
BACKGROUND 3'-Deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762, PNU 152243) is a highly lipophilic doxorubicin… (More)
Is this relevant?
1995
1995
Methoxymorpholinyldoxorubicin (FCE 23762) is a novel, highly lipophilic doxorubicin analogue. It possesses potent in vitro and in… (More)
Is this relevant?
1994
1994
We investigated the mechanism of resistance in murine L1210 leukaemia cells selected after treatment with FCE 23762… (More)
  • figure 2
  • table I
  • table II
  • table III
  • table IV
Is this relevant?
1993
1993
The purpose of this study was to examine the cytotoxicity and cardiotoxicity of the new doxorubicin derivative, 3'-deamino-3'-(2… (More)
Is this relevant?
1993
1993
A simple, rapid and reproducible high-performance thin-layer chromatographic (HPTLC) method using UV or fluorescence scanning… (More)
Is this relevant?
1993
1993
Intracellular glutathione (GSH) content was measured by flow cytometry using monochlorobimane (mBCl) and by the enzymatic assay… (More)
Is this relevant?
1992
1992
FCE 23762 is a new doxorubicin derivative obtained by appending a methoxymorpholinyl group at position 3' of the sugar moiety… (More)
  • figure 1
  • table I
  • table IV
  • table II
  • table III
Is this relevant?
1992
1992
FCE 23762 (3′ desamino-3′[2(s)methoxyl-4-morpholinyl]doxorubicin) is a new doxorubicin (Dx) derivative that has been selected for… (More)
  • figure 2
  • figure 1
  • figure 3
Is this relevant?